Literature DB >> 25356051

Membrane-bound mucins and mucin terminal glycans expression in idiopathic or Helicobacter pylori, NSAID associated peptic ulcers.

Yaron Niv1, Doron Boltin1, Marisa Halpern1, Miriam Cohen1, Zohar Levi1, Alex Vilkin1, Sara Morgenstern1, Vahig Manugian1, Erica St Lawrence1, Pascal Gagneux1, Sukhwinder Kaur1, Poonam Sharma1, Surinder K Batra1, Samuel B Ho1.   

Abstract

AIM: To determine the expression of membrane-bound mucins and glycan side chain sialic acids in Helicobacter pylori (H. pylori)-associated, non-steroidal inflammatory drug (NSAID)-associated and idiopathic-gastric ulcers.
METHODS: We studied a cohort of randomly selected patients with H. pylori (group 1, n = 30), NSAID (group 2, n = 18), combined H. pylori and NSAID associated gastric ulcers (group 3, n = 24), and patients with idiopathic gastric ulcers (group 4, n = 20). Immunohistochemistry for MUC1, MUC4, MUC17, and staining for Erythrina cristagalli agglutinin and Sambucus nigra agglutinin (SNA) lectins was performed on sections from the ulcer margins.
RESULTS: Staining intensity of MUC17 was higher in H. pylori ulcers (group 1) than in idiopathic ulcers (group 4), 11.05 ± 3.67 vs 6.93 ± 4.00 for foveola cells, and 10.29 ± 4.67 vs 8.00 ± 3.48 for gland cells, respectively (P < 0.0001). In contrast, MUC1 expression was higher in group 4 compared group 1, 9.89 ± 4.17 vs 2.93 ± 5.13 in foveola cells and 7.63 ± 4.60 vs 2.57± 4.50 for glands, respectively (P < 0.0001). SNA lectin staining was increased in group 4, in parallel to elevated MUC1 expression, indicating more abundant α2-6 sialylation in that group.
CONCLUSION: Cytoplasmic MUC17 staining was significantly decreased in the cases with idiopathic ulcer. The opposite was observed for both MUC1 and SNA lectin. This observation may reflect important pathogenic mechanisms, since different mucins with altered sialylation patterns may differ in their protection efficiency against acid and pepsin.

Entities:  

Keywords:  Glycosylation; Helicobacter pylori; Idiopathic ulcer; Mucin; Mucosal cytoprotection; Peptic ulcer disease

Mesh:

Substances:

Year:  2014        PMID: 25356051      PMCID: PMC4209554          DOI: 10.3748/wjg.v20.i40.14913

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

Review 1.  Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells.

Authors:  S Bafna; S Kaur; S K Batra
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

2.  Activity of recombinant cysteine-rich domain proteins derived from the membrane-bound MUC17/Muc3 family mucins.

Authors:  Samuel B Ho; Ying Luu; Laurie L Shekels; Surinder K Batra; Brandon Kandarian; David B Evans; Phillip G Zaworski; Cindy L Wolfe; Robert L Heinrikson
Journal:  Biochim Biophys Acta       Date:  2010-03-20

3.  Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis.

Authors:  Ying Luu; Wade Junker; Satyanarayana Rachagani; Srustidhar Das; Surinder K Batra; Robert L Heinrikson; Laurie L Shekels; Samuel B Ho
Journal:  Int J Biochem Cell Biol       Date:  2010-03-06       Impact factor: 5.085

4.  Role of mucin Lewis status in resistance to Helicobacter pylori infection in pediatric patients.

Authors:  Sara Lindén; Cristina Semino-Mora; Hui Liu; James Rick; Andre Dubois
Journal:  Helicobacter       Date:  2010-08       Impact factor: 5.753

5.  High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers.

Authors:  Grace Lai-Hung Wong; Vincent Wai-Sun Wong; Yawen Chan; Jessica Yuet-Ling Ching; Kim Au; Aric Josun Hui; Larry Hin Lai; Dorothy Kai-Lai Chow; Danny Ka-Fai Siu; Yan-Ni Lui; Justin Che-Yuen Wu; Ka-Fai To; Lawrence Cheung-Tsui Hung; Henry Lik-Yuen Chan; Joseph Jao-Yiu Sung; Francis Ka-Leung Chan
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

6.  Helicobacter pylori moves through mucus by reducing mucin viscoelasticity.

Authors:  Jonathan P Celli; Bradley S Turner; Nezam H Afdhal; Sarah Keates; Ionita Ghiran; Ciaran P Kelly; Randy H Ewoldt; Gareth H McKinley; Peter So; Shyamsunder Erramilli; Rama Bansil
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-11       Impact factor: 11.205

Review 7.  Review article: Helicobacter pylori-negative duodenal ulcer disease.

Authors:  J P Gisbert; X Calvet
Journal:  Aliment Pharmacol Ther       Date:  2008-07-23       Impact factor: 8.171

Review 8.  How I manage H. pylori-negative, NSAID/aspirin-negative peptic ulcers.

Authors:  Kenneth E L McColl
Journal:  Am J Gastroenterol       Date:  2009-01       Impact factor: 10.864

9.  The gastric mucus layers: constituents and regulation of accumulation.

Authors:  Mia Phillipson; Malin E V Johansson; Johanna Henriksnäs; Joel Petersson; Sandra J Gendler; Stellan Sandler; A Erik G Persson; Gunnar C Hansson; Lena Holm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-21       Impact factor: 4.052

Review 10.  Roles of gastric mucin-type O-glycans in the pathogenesis of Helicobacter pylori infection.

Authors:  Motohiro Kobayashi; Heeseob Lee; Jun Nakayama; Minoru Fukuda
Journal:  Glycobiology       Date:  2009-01-15       Impact factor: 4.313

View more
  4 in total

1.  Immunosuppressive agents are associated with peptic ulcer bleeding.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Rumiko Hasegawa; Yoshinori Shirai; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  Exp Ther Med       Date:  2017-03-09       Impact factor: 2.447

Review 2.  Helicobacter pylori and gastric mucin expression: A systematic review and meta-analysis.

Authors:  Yaron Niv
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

Review 3.  A systematic approach for the diagnosis and treatment of idiopathic peptic ulcers.

Authors:  Chen-Shuan Chung; Tsung-Hsien Chiang; Yi-Chia Lee
Journal:  Korean J Intern Med       Date:  2015-08-27       Impact factor: 2.884

4.  Upregulation of MUC5AC production and deposition of LEWIS determinants by HELICOBACTER PYLORI facilitate gastric tissue colonization and the maintenance of infection.

Authors:  Weronika Gonciarz; Maria Walencka; Anthony P Moran; Krzysztof Hinc; Michał Obuchowski; Magdalena Chmiela
Journal:  J Biomed Sci       Date:  2019-03-06       Impact factor: 8.410

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.